vs
Astrana Health, Inc.（ASTH）与Martin Marietta Materials（MLM）财务数据对比。点击上方公司名可切换其他公司
Martin Marietta Materials的季度营收约是Astrana Health, Inc.的1.2倍（$1.1B vs $950.5M），Martin Marietta Materials净利率更高（24.5% vs 0.7%，领先23.8%），Astrana Health, Inc.同比增速更快（42.9% vs -30.1%），Martin Marietta Materials自由现金流更多（$424.0M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs -4.5%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
马丁·玛丽埃塔材料公司是美国大型集料及重型建筑材料供应商，业务覆盖美国26个州、加拿大及加勒比地区，主要为道路、人行道、地基等各类基建项目提供所需原材料。
ASTH vs MLM — 直观对比
营收规模更大
MLM
是对方的1.2倍
$950.5M
营收增速更快
ASTH
高出73.0%
-30.1%
净利率更高
MLM
高出23.8%
0.7%
自由现金流更多
MLM
多$429.9M
$-6.0M
两年增速更快
ASTH
近两年复合增速
-4.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.1B |
| 净利润 | $6.6M | $279.0M |
| 毛利率 | — | 35.0% |
| 营业利润率 | 1.9% | 24.6% |
| 净利率 | 0.7% | 24.5% |
| 营收同比 | 42.9% | -30.1% |
| 净利润同比 | 184.4% | -4.8% |
| 每股收益（稀释后） | $0.12 | $4.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHMLM
| Q4 25 | $950.5M | $1.1B | ||
| Q3 25 | $956.0M | $1.8B | ||
| Q2 25 | $654.8M | $1.8B | ||
| Q1 25 | $620.4M | $1.4B | ||
| Q4 24 | $665.2M | $1.6B | ||
| Q3 24 | $478.7M | $1.9B | ||
| Q2 24 | $486.3M | $1.8B | ||
| Q1 24 | $404.4M | $1.3B |
净利润ASTHMLM
| Q4 25 | $6.6M | $279.0M | ||
| Q3 25 | $373.0K | $414.0M | ||
| Q2 25 | $9.4M | $328.0M | ||
| Q1 25 | $6.7M | $116.0M | ||
| Q4 24 | $-7.8M | $293.0M | ||
| Q3 24 | $16.1M | $363.0M | ||
| Q2 24 | $19.2M | $294.0M | ||
| Q1 24 | $14.8M | $1.0B |
毛利率ASTHMLM
| Q4 25 | — | 35.0% | ||
| Q3 25 | — | 33.1% | ||
| Q2 25 | — | 30.0% | ||
| Q1 25 | — | 24.8% | ||
| Q4 24 | — | 30.0% | ||
| Q3 24 | — | 31.7% | ||
| Q2 24 | — | 29.3% | ||
| Q1 24 | — | 21.7% |
营业利润率ASTHMLM
| Q4 25 | 1.9% | 24.6% | ||
| Q3 25 | 2.0% | 27.4% | ||
| Q2 25 | 3.1% | 25.3% | ||
| Q1 25 | 3.3% | 14.3% | ||
| Q4 24 | 0.1% | 24.4% | ||
| Q3 24 | 5.9% | 25.9% | ||
| Q2 24 | 6.2% | 22.6% | ||
| Q1 24 | 7.5% | — |
净利率ASTHMLM
| Q4 25 | 0.7% | 24.5% | ||
| Q3 25 | 0.0% | 22.4% | ||
| Q2 25 | 1.4% | 18.1% | ||
| Q1 25 | 1.1% | 8.6% | ||
| Q4 24 | -1.2% | 18.0% | ||
| Q3 24 | 3.4% | 19.2% | ||
| Q2 24 | 3.9% | 16.7% | ||
| Q1 24 | 3.7% | 83.5% |
每股收益（稀释后）ASTHMLM
| Q4 25 | $0.12 | $4.59 | ||
| Q3 25 | $0.01 | $6.85 | ||
| Q2 25 | $0.19 | $5.43 | ||
| Q1 25 | $0.14 | $1.90 | ||
| Q4 24 | $-0.14 | $4.87 | ||
| Q3 24 | $0.33 | $5.91 | ||
| Q2 24 | $0.40 | $4.76 | ||
| Q1 24 | $0.31 | $16.87 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $67.0M |
| 总债务越低越好 | — | $5.3B |
| 股东权益账面价值 | $779.3M | $10.0B |
| 总资产 | $2.2B | $18.7B |
| 负债/权益比越低杠杆越低 | — | 0.53× |
8季度趋势，按日历期对齐
现金及短期投资ASTHMLM
| Q4 25 | $429.5M | $67.0M | ||
| Q3 25 | $463.4M | $57.0M | ||
| Q2 25 | $342.1M | $225.0M | ||
| Q1 25 | $260.9M | $101.0M | ||
| Q4 24 | $290.8M | $670.0M | ||
| Q3 24 | $350.3M | $52.0M | ||
| Q2 24 | $327.7M | $109.0M | ||
| Q1 24 | $337.3M | $2.6B |
总债务ASTHMLM
| Q4 25 | — | $5.3B | ||
| Q3 25 | — | $5.5B | ||
| Q2 25 | — | $5.4B | ||
| Q1 25 | — | $5.4B | ||
| Q4 24 | — | $5.4B | ||
| Q3 24 | — | $4.0B | ||
| Q2 24 | — | $4.3B | ||
| Q1 24 | — | $4.3B |
股东权益ASTHMLM
| Q4 25 | $779.3M | $10.0B | ||
| Q3 25 | $775.5M | $9.7B | ||
| Q2 25 | $765.5M | $9.4B | ||
| Q1 25 | $745.4M | $9.1B | ||
| Q4 24 | $712.7M | $9.5B | ||
| Q3 24 | $704.6M | $9.2B | ||
| Q2 24 | $678.9M | $8.8B | ||
| Q1 24 | $653.5M | $8.9B |
总资产ASTHMLM
| Q4 25 | $2.2B | $18.7B | ||
| Q3 25 | $2.2B | $18.7B | ||
| Q2 25 | $1.4B | $18.1B | ||
| Q1 25 | $1.3B | $17.7B | ||
| Q4 24 | $1.4B | $18.2B | ||
| Q3 24 | $1.3B | $16.5B | ||
| Q2 24 | $1.3B | $16.3B | ||
| Q1 24 | $1.2B | $16.2B |
负债/权益比ASTHMLM
| Q4 25 | — | 0.53× | ||
| Q3 25 | — | 0.57× | ||
| Q2 25 | — | 0.58× | ||
| Q1 25 | — | 0.60× | ||
| Q4 24 | — | 0.57× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.49× | ||
| Q1 24 | — | 0.49× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $629.0M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $424.0M |
| 自由现金流率自由现金流/营收 | -0.6% | 37.2% |
| 资本支出强度资本支出/营收 | 0.3% | 18.0% |
| 现金转化率经营现金流/净利润 | -0.44× | 2.25× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $978.0M |
8季度趋势，按日历期对齐
经营现金流ASTHMLM
| Q4 25 | $-2.9M | $629.0M | ||
| Q3 25 | $10.0M | $551.0M | ||
| Q2 25 | $90.9M | $387.0M | ||
| Q1 25 | $16.6M | $218.0M | ||
| Q4 24 | $-10.9M | $686.0M | ||
| Q3 24 | $34.0M | $600.0M | ||
| Q2 24 | $23.2M | $1.0M | ||
| Q1 24 | $6.0M | $172.0M |
自由现金流ASTHMLM
| Q4 25 | $-6.0M | $424.0M | ||
| Q3 25 | $7.4M | $361.0M | ||
| Q2 25 | $89.5M | $208.0M | ||
| Q1 25 | $13.6M | $-15.0M | ||
| Q4 24 | $-13.5M | $453.0M | ||
| Q3 24 | $31.7M | $317.0M | ||
| Q2 24 | $20.4M | $-138.0M | ||
| Q1 24 | $5.6M | $-28.0M |
自由现金流率ASTHMLM
| Q4 25 | -0.6% | 37.2% | ||
| Q3 25 | 0.8% | 19.6% | ||
| Q2 25 | 13.7% | 11.5% | ||
| Q1 25 | 2.2% | -1.1% | ||
| Q4 24 | -2.0% | 27.8% | ||
| Q3 24 | 6.6% | 16.8% | ||
| Q2 24 | 4.2% | -7.8% | ||
| Q1 24 | 1.4% | -2.2% |
资本支出强度ASTHMLM
| Q4 25 | 0.3% | 18.0% | ||
| Q3 25 | 0.3% | 10.3% | ||
| Q2 25 | 0.2% | 9.9% | ||
| Q1 25 | 0.5% | 17.2% | ||
| Q4 24 | 0.4% | 14.3% | ||
| Q3 24 | 0.5% | 15.0% | ||
| Q2 24 | 0.6% | 7.9% | ||
| Q1 24 | 0.1% | 16.0% |
现金转化率ASTHMLM
| Q4 25 | -0.44× | 2.25× | ||
| Q3 25 | 26.69× | 1.33× | ||
| Q2 25 | 9.65× | 1.18× | ||
| Q1 25 | 2.48× | 1.88× | ||
| Q4 24 | — | 2.34× | ||
| Q3 24 | 2.11× | 1.65× | ||
| Q2 24 | 1.21× | 0.00× | ||
| Q1 24 | 0.40× | 0.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
MLM
| Building Materials Business East Group | $774.0M | 68% |
| Building Materials Business West Group | $233.0M | 20% |
| Services | $88.0M | 8% |
| Other | $45.0M | 4% |
